Interview with a FDA Process expert..., page-41

"From a commercial perspective, X also mentioned in isolation of anything else, it is once the data starts coming back and it is shown to be efficacious and safe, that's when the share price will lift significantly."

Thanks for all your hard work and sharing this with us Mozzarc.

Just wanted to clarify the above. Will PAR be releasing results of the participants (1,150) while the trial is on-going, kind of like the SAS? Or do they wait until all 1,150 participants have completed the trial and results are known. I would have thought it is the latter but saw the comment above and thought I would ask the question.